inhaled nitric oxide 75 mcg/kg IBW/hr

DRUG2 trials

Sponsors

Bellerophon, Bellerophon Pulse Technologies

Conditions

Chronic Obstructive Pulmonary DiseaseIdiopathic Pulmonary FibrosisPulmonary Arterial HypertensionPulmonary Hypertension

Phase 1

3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF

CompletedNCT02267655

BellerophonChronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension

Start: 2015-05-31End: 2017-06-28Updated: 2023-02-21

Phase 3

Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

TerminatedNCT02725372

Bellerophon Pulse TechnologiesPulmonary Arterial Hypertension

Start: 2016-04-30End: 2018-08-31Updated: 2023-02-21